Philips Inflationary-Based Non-Invasive Blood Pressure Validation Study

Inclusion Criteria: * Participants must be 3 to 85 years of age. * Participants, parents or legal guardians of participants must be able to provide informed consent, parental permission, and/or assent form. * Participants that are between 7 and 17 (inclusive) years of age must provide assent to participate in the study. * Participants, parents or legal guardians of participants must be able to read or write in English and participants that are between the age of 7-17 must be able to understand English to provide assent. * Participant must be willing and able to comply with study procedures and duration. * Participants must have an upper arm circumference in the range of 14-43 centimeters. Exclusion Criteria: * Participant, parent or legal guardian of participant is unwilling to provide informed consent, parental permission, and/or assent. * Participants with deformities or abnormalities that may prevent proper application of the device under test. * Participants with an upper arm circumference less than 14 cm or greater than 43 cm. * Female participants who are pregnant. * Female participants who are trying to get pregnant with confirmation of positive urine pregnancy test. * Participants with known heart arrhythmias. * Participants with peripheral vascular disease. * Participants with clotting disorders. * History of bleeding disorders or personal history of prolonged bleeding from injury. * History of blood clots. * Hemophilia. * Participants that cannot tolerate sitting for up to 1-2 hours. * Participant with a blood pressure or other demographics that have already been filled. * Other known health conditions that will prevent safe participation in the study upon disclosure in screening form or verbally. * Participant is evaluated by the investigator or clinician and found to be medically unsuitable for participation in this study. * Participants where the Korotkoff sounds (fifth phase (K5)) for determining DBP is not audible.